tiprankstipranks
Liminatus Pharma, Inc. (LIMN)
NASDAQ:LIMN
US Market
LIMN
Liminatus Pharma
RESEARCH TOOLSreports
Want to see LIMN full AI Analyst Report?

Liminatus Pharma (LIMN) Financial Statements

88 Followers

Liminatus Pharma Financial Overview

Liminatus Pharma's market cap is currently $8.33M. The company's EPS TTM is $; its P/E ratio is -0.44; Liminatus Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -2.97M$ -2.91M$ -2.59M$ -2.71M$ -2.53M
EBITDA$ -9.99M$ -2.75M$ -1.09M$ -2.71M$ 4.37M
Net Income$ -10.21M$ -2.90M$ -1.23M$ -2.93M$ 4.37M
Balance Sheet
Cash & Short-Term Investments$ 337.65K$ 804.54K$ 434.00K$ 5.05M$ 336.23K
Total Assets$ 512.79K$ 2.83M$ 4.50M$ 15.49M$ 276.44M
Total Debt$ 1.44M$ 5.12M$ 16.05M$ 16.50M$ 90.00K
Net Debt$ 1.10M$ 4.32M$ 15.62M$ 11.45M$ -246.23K
Total Liabilities$ 10.33M$ 18.70M$ 15.19M$ 14.19M$ 21.57M
Stockholders' Equity$ -9.81M$ -15.87M$ -10.69M$ 1.29M$ 254.87M
Cash Flow
Free Cash Flow$ -9.98M$ -3.11M$ -3.35M$ -869.00K$ -1.22M
Operating Cash Flow$ -9.96M$ -3.11M$ -3.35M$ -869.00K$ -1.22M
Investing Cash Flow$ -788.11K$ 1.97M$ -819.00K$ 0.00$ -276.00M
Financing Cash Flow$ 11.03M$ 1.05M$ -450.00K$ 5.92M$ 277.55M
Currency in USD

Liminatus Pharma Earnings and Revenue History

Income Statement >

Liminatus Pharma Debt to Assets

Balance Sheet >

Liminatus Pharma Cash Flow

Cash Flow >

Liminatus Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >